×
For best experience we recommend to activate Javascript in your browser.
RNF34 antibody (AA 1-373)
The Rabbit Polyclonal anti-RNF34 antibody has been validated for WB, ELISA and IF. It is suitable to detect RNF34 in samples from Human.
Quick Overview for RNF34 antibody (AA 1-373) (ABIN2352857)
Target
See all RNF34 Antibodies
RNF34
(Ring Finger Protein 34 (RNF34))
Reactivity
All reactivities for RNF34 antibodies
Human
Host
All hosts for RNF34 antibodies
Rabbit
Clonality
All clonalities for RNF34 antibodies
Polyclonal
Conjugate
All conjugates for RNF34 antibodies
This RNF34 antibody is un-conjugated
Application
All applications for RNF34 antibodies
Western Blotting (WB), ELISA, Immunofluorescence (IF)
Product Details anti-RNF34 Antibody
(hide)
Binding Specificity
All epitopes for RNF34 antibodies
AA 1-373
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
RNF34 (E3 Ubiquitin-protein Ligase RNF34, Caspase Regulator CARP1, Caspases-8 and -10-associated RING Finger Protein 1, CARP-1, FYVE-RING Finger Protein Momo, Human RING Finger Homologous to Inhibitor of Apoptosis Protein, hRFI, RING Finger Protein 34, RING Finger Protein RIFF)
Purification
Purified by Protein A affinity chromatography.
Immunogen
Recombinant protein corresponding to aa1-373 from human RNF34.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Reconstitution
Reconstitute with sterile dH2O or PBS.
Buffer
Supplied as a lyophilized powder in 0.02M potassium phosphate, 0.15M sodium chloride, pH 7.2, 0.01 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for RNF34
(hide)
Target
RNF34
(Ring Finger Protein 34 (RNF34))
Alternative Name
RNF34
Recently viewed
(hide)
Chat with us , powered by LiveChat